Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFUSE-AT: Hylenex-facilitated SC Fluid Administration
NCT00807885Phase 4Completed
- Sponsor
- Baxter
- Start
- Dec 2008
- Primary completion
- Jan 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human hyaluronidase PH20 in dehydration, sponsored by Baxter. Started Dec 2008; status: completed.
02
Drugs
recombinant human hyaluronidase PH20
03
Conditions
dehydration
Beyond the preview
Go deeper on NCT00807885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00807885.